A Risk Model for Predicting Fetuses with Trisomy 21 Using Alpha-Fetoprotein Variants L2 Combined with Maternal Serum Biomarkers in Early Pregnancy

To establish a risk prediction model and the clinical value of trisomy 21 using alpha-fetoprotein variants L2 (AFP-L2) combined with maternal serum biomarkers and nuchal translucency (NT) thickness in early pregnancy. A retrospective case–control study was conducted. The subjects were divided into t...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yiming, Wu, Bin, Chen, Yijie, Ning, Wenwen, Zhang, Huimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Maternal Fetal Medicine/Biology: Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907085/
https://www.ncbi.nlm.nih.gov/pubmed/34750768
http://dx.doi.org/10.1007/s43032-021-00762-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907085/
https://www.ncbi.nlm.nih.gov/pubmed/34750768
http://dx.doi.org/10.1007/s43032-021-00762-5

Ejemplares similares